Latest News and Press Releases
Want to stay updated on the latest news?
-
April 13, 2018Announcement no. 8 BioPorto A/S held its Annual General Meeting today where the shareholders approved the report on the Company’s activities and adopted the 2017 Annual Report. In...
-
21. marts 2018 Meddelelses nummer: 6 Indkaldelse til ordinær generalforsamling Bestyrelsen indkalder herved til ordinær generalforsamling i BioPorto A/S: Den 13. april 2018, kl. 15.00 På...
-
March 21, 2018 Announcement no. 6 ...
-
BioPorto har i 2017 fokuseret på at skabe vækst og sikre en målrettet eksekvering af topprioriteterne på den strategiske agenda; at styrke opmærksomheden om anvendelse af Neutrophil Gelatinase...
-
BioPorto A/S (“BioPorto”) has entered into a global distribution agreement with Roche, under which BioPorto will deliver a neutrophil gelatinase-associated lipocalin (NGAL) test for use on Roche’s...
-
Pursuant to section 10 of executive order no. 1526 of December 9, 2016 on Issuers' Disclosure Obligations, it is hereby announced, that BioPorto A/S total share capital amounts to DKK 155.509.681...
-
The share capital of BioPorto A/S will be increased on Nasdaq Copenhagen. The admittance of trading and official listing of new shares will take effect as per 8 November 2017 in the ISIN...
-
Aktiekapitalen i BioPorto A/S vil med virkning fra den 8. november 2017 blive forhøjet på Nasdaq Copenhagen. Optagelse til handel og officiel notering af nye aktier vil ske i nedenstående...
-
BioPorto A/S has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in BioPorto A/S made by persons discharging managerial...
-
The Board of Directors of BioPorto A/S (BioPorto) decided on October 27, 2017 to partially exercise the authorization in article 16b of the company’s Articles of Association to issue new shares in a...